Furthermore, they showed that antibody‐mediated targeting of PD‐L1 or CRISPR‐mediated depletion of PD‐L1 both reduced the level of pulmonary fibrosis in NSG recipient mice.84 Here, CD274 is linked to pulmonary fibrosis.